Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Submit a comment

Superoxide Production by Digitonin-Stimulated Guinea Pig Granulocytes: THE EFFECTS OF N-ETHYL MALEIMIDE, DIVALENT CATIONS, AND GLYCOLYTIC AND MITOCHONDRIAL INHIBITORS ON THE ACTIVATION OF THE SUPEROXIDE GENERATING SYSTEM
Harvey J. Cohen, Margaret E. Chovaniec
Harvey J. Cohen, Margaret E. Chovaniec
Published April 1, 1978
Citation Information: J Clin Invest. 1978;61(4):1088-1096. https://doi.org/10.1172/JCI109008.
View: Text | PDF

Superoxide Production by Digitonin-Stimulated Guinea Pig Granulocytes: THE EFFECTS OF N-ETHYL MALEIMIDE, DIVALENT CATIONS, AND GLYCOLYTIC AND MITOCHONDRIAL INHIBITORS ON THE ACTIVATION OF THE SUPEROXIDE GENERATING SYSTEM

  • Text
  • PDF
Abstract

N-ethylmaleimide, divalent cations, ethylene glycol bis (β aminoethyl ether) N,N,N′,N′,-tetraacetate, 2-deoxyglucose, cyanide, and dinitrophenol were examined for their effect on the ability of guinea pig granulocytes to generate superoxide (O2−) when stimulated by digitonin. N-ethylmaleimide (1 mM) inhibits only when added before complete activation of the O2− generating system, and at lower concentrations (0.05-0.2 mM) slows the activation process. Ca++ is required for maximum O2− generation, and Mg++ decreases the amount of Ca++ required. Ethylene glycol bis (β aminoethyl ether) N,N,N′,N′,-tetraacetate (10 mM) inhibits only if added before complete activation. Incubation of cells in 2-DOG causes a time- and concentration-dependent inhibition of O2− generation. It also increases the time required for activation of this system. Cyanide and dinitrophenol increase the rate of O2− production. However, when these compounds are added to cells whose O2− production is partially inhibited by incubation in 2-deoxyglucose, complete inhibition results. If cyanide or dinitrophenol is added after activation of 2-deoxyglucose-treated cells, no further inhibition occurs. On the basis of the above results, we conclude that the activation of the O2− generating system is N-ethylmaleimide sensitive, Ca++ dependent, and energy requiring, but that the activity of the enzyme system in the cell is not.

Authors

Harvey J. Cohen, Margaret E. Chovaniec

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts